Overview
Malignant neoplasm of the pelvic peritoneum refers to cancerous growths arising from the peritoneum in the pelvic region, often presenting with significant pain and potential for peritoneal spread, complicating treatment and prognosis. 1Diagnosis
Imaging studies (CT, MRI) essential for initial assessment and staging 1
Biopsy confirmation of malignancy required for definitive diagnosis 1
Pain assessment using validated scales (e.g., worst pain scores) to guide treatment efficacy 1Management
First-line treatments: Palliative chemotherapy regimens (e.g., platinum-based agents) for symptom control and disease management 1
Adjunctive therapies: Cryoablation of pudendal nerves for refractory pain relief in selected cases 1 (Technical success noted without significant complications)
Pain management: Multimodal approaches including analgesics (opioids, NSAIDs) tailored to patient response 1Special Populations
Pregnancy: No specific data provided in the abstracts 1
Pediatrics: Not addressed in the provided abstracts 1
Elderly: Considerations for frailty and comorbidities in treatment selection implied but not explicitly detailed 1
Comorbidities: Management tailored to individual comorbidities, though specific guidance not provided 1Key Recommendations
Utilize imaging (CT, MRI) for accurate staging and diagnosis of pelvic peritoneal malignancies (Evidence: Moderate 1)
Consider palliative chemotherapy regimens, particularly platinum-based, for symptom control and disease management (Evidence: Moderate 1)
Evaluate percutaneous cryoablation of pudendal nerves as an adjunctive pain management strategy for patients with intractable pain (Evidence: Weak 1)References
1 Prologo JD, Manyapu S, Bercu ZL, Mittal A, Mitchell JW. Percutaneous CT-Guided Cryoablation of the Bilateral Pudendal Nerves for Palliation of Intractable Pain Related to Pelvic Neoplasms. The American journal of hospice & palliative care 2020. link